Market Place
Sourcing Support
Glycomine Appoints Joshua Grass as Chairperson of Board of Directors
10 Oct 2024 //
BUSINESSWIRE
Glycomine Gets FDA Fast Track For GLM101 In PMM2-CDG
18 Sep 2024 //
BUSINESSWIRE
Glycomine Announces Encouraging Efficacy Data from Phase 2 Study in PMM2-CDG
04 Mar 2024 //
BUSINESSWIRE
Glycomine Announces First Pediatric Patient Dosed in Phase 2 Study of GLM101
11 Dec 2023 //
BUSINESSWIRE
Glycomine Presents at ASHG 2023 Data from Ongoing Natural History Study
02 Nov 2023 //
BUSINESSWIRE
Glycomine Appoints Dr. Rose Marino Chief Medical Officer
12 Oct 2023 //
BUSINESSWIRE
Data from Glycomine’s Ongoing Natural History Study Provides Insight PMM2-CDG
30 Aug 2023 //
BUSINESSWIRE
Glycomine Announces First Patient Dosed in Phase 2 Study of GLM101
09 Jan 2023 //
BUSINESSWIRE
Glycomine Announces First Dosing in Phase 1 Clinical Study of GLM101
17 Dec 2021 //
BUSINESSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.